BACKGROUND: Endometrial cancer is the most common gynecological malignancy in developed countries with no screening available. There is still a tendency to provide invasive bioptic verification in asymptomatic women with abnormal ultrasound findings to diagnose carcinoma in a preclinical phase; even though, it is not supported by European guidelines. Our goal was to determine DFS (disease-free survival), OS (overall survival), and DSS (disease-specific survival) differences between symptom-free and symptomatic (bleeding, or spotting) endometrial cancer patients with similar stage and tumor/clinical characteristics. METHODS: All of our patients with endometrial cancer following surgical treatment between 2006 and 2019 were assessed, evaluating risk factors for recurrence and death while focusing on bleeding using univariable and multivariable analysis. RESULTS: 625 patients meeting the inclusion criteria were divided into asymptomatic (n = 144, 23%) and symptomatic (n = 481, 77%) groups. The median follow-up was 3.6 years. Using univariable analysis, symptomatic patients had a three times higher risk of recurrence (HR 3.1 (95% Cl 1.24-7.77), p = 0.016). OS (HR 1.35 (0.84-2.19), p = 0.219) and DSS (HR 1.66 (0.64-4.28), p = 0.3) were slightly worse without reaching statistical significance. In our multivariable analysis, symptomatology was deemed completely insignificant in all monitored parameters (DFS: HR 2.03 (0.79-5.24), p = 0.144; OS: HR 0.72 (0.43-1.21), p = 0.216). CONCLUSIONS: The symptomatic endometrial cancer patients risk factor of earlier recurrence and death is insignificantly higher when compared with the asymptomatic cohort. However, multivariable analysis verifies that prognosis worsens with other clinically relevant parameters, not by symptomatology itself. In terms of survival outcome in EC patients, we recognized symptomatology as a non-significant marker for the patient's prognosis.

Department of Gynecology and Obstetrics University Hospital Brno and Faculty of Medicine Masaryk University 60200 Brno Czech Republic

Department of Internal Medicine Hematology and Oncology University Hospital Brno and Faculty of Medicine Masaryk University 60200 Brno Czech Republic

Department of Pathology University Hospital Brno and Faculty of Medicine Masaryk University 60200 Brno Czech Republic

Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University 60200 Brno Czech Republic

See more in PubMed

Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. PubMed DOI

Clarke M.A., Long B.J., Del Mar Morillo A., Arbyn M., Bakkum-Gamez J.N., Wentzensen N. Association of Endometrial Cancer Risk with Postmenopausal Bleeding in Women. JAMA Intern. Med. 2018;178:1210–1222. doi: 10.1001/jamainternmed.2018.2820. PubMed DOI PMC

Sant M., Lopez M.D.C., Agresti R., Pérez M.J.S., Holleczek B., Bielska-Lasota M., Dimitrova N., Innos K., Katalinic A., Langseth H., et al. Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study. Eur. J. Cancer. 2015;51:2191–2205. doi: 10.1016/j.ejca.2015.07.022. PubMed DOI

Quinn M.A., Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P., Nyan H.Y., Pecorelli S. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 2006;95((Suppl. 1)):S105–S143. PubMed

Colombo N., Creutzberg C., Amant F., Bosse T., Martín A.G., Ledermann J., Marth C., Nout R.A., Querleu D., Mirza M.R., et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. Int. J. Gynecol. Cancer. 2016;26:2–30. doi: 10.1097/IGC.0000000000000609. PubMed DOI PMC

Vrede S., van Weelden W., Visser N., Bulten J., van der Putten L., van de Vijver K., Santacana M., Colas E., Gil-Moreno A., Moiola C., et al. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. Gynecol. Oncol. 2021;161:787–794. doi: 10.1016/j.ygyno.2021.03.031. PubMed DOI

Getz G., Gabriel S.B., Cibulskis K., Lander E., Sivachenko A., Sougnez C., Lawrence M., Kandoth C., Dooling D., Fulton R., et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67–73. PubMed PMC

Concin N., Matias-Guiu X., Vergote I., Cibula D., Mirza M.R., Marnitz S., Ledermann J., Bosse T., Chargari C., Fagotti A., et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int. J. Gynecol. Cancer. 2021;31:12–39. doi: 10.1136/ijgc-2020-002230. PubMed DOI

Uglietti A., Buggio L., Farella M., Chiaffarino F., Dridi D., Vercellini P., Parazzini F. The risk of malignancy in uterine polyps: A systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019;237:48–56. doi: 10.1016/j.ejogrb.2019.04.009. PubMed DOI

Alcázar J.L., Bonilla L., Marucco J., Padilla A.I., Chacón E., Manzour N., Salas A. Risk of endometrial cancer and endometrial hyperplasia with atypia in asymptomatic postmenopausal women with endometrial thickness ≥11 mm: A systematic review and meta-analysis. J. Clin. Ultrasound. 2018;46:565–570. doi: 10.1002/jcu.22631. PubMed DOI

Onkogynekologie.com. [(accessed on 19 October 2021)]. Available online: http://www.onkogynekologie.com/

NCI Dictionary of Cancer Terms—National Cancer Institute. Published 2 February 2011. [(accessed on 26 June 2021)]; Available online: https://www.cancer.gov/publications/dictionaries/cancer-terms/

Jokubkiene L., Sladkevicius P., Valentin L. Transvaginal ultrasound examination of the endometrium in postmenopausal women without vaginal bleeding. Ultrasound Obstet. Gynecol. 2016;48:390–396. doi: 10.1002/uog.15841. PubMed DOI

Smith-Bindman R., Weiss E., Feldstein V. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet. Gynecol. 2004;24:558–565. doi: 10.1002/uog.1704. PubMed DOI

Vinklerová P., Felsinger M., Frydová S., Ovesná P., Hausnerová J., Weinberger V. Is the finding of endometrial hyperplasia or corporal polyp an mandatory indication for biopsy? Ceska Gynekol. 2020;85:84–93. PubMed

Ferrazzi E., Zupi E., Leone F.P., Savelli L., Omodei U., Moscarini M., Barbieri M., Cammareri G., Capobianco G., Cicinelli E., et al. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Am. J. Obstet. Gynecol. 2009;200:235.e1–235.e6. doi: 10.1016/j.ajog.2008.09.876. PubMed DOI

Scrimin F., Wiesenfeld U., Galati E.F., Monasta L., Ricci G. Hysteroscopic chasing for endometrial cancer in a low-risk population: Risks of overinvestigation. Arch. Gynecol. Obstet. 2016;293:851–856. doi: 10.1007/s00404-015-3868-x. PubMed DOI

Vinklerová P., Bednaříková M., Minář L., Felsinger M., Hausnerová J., Ovesná P., Weinberger V. Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer. Healthcare. 2021;9:902. doi: 10.3390/healthcare9070902. PubMed DOI PMC

Gemer O., Segev Y., Helpman L., Hag-Yahia N., Eitan R., Raban O., Vaknin Z., Leytes S., Ben Arie A., Amit A., et al. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study. Am. J. Obstet. Gynecol. 2018;219:181.e1–181.e6. doi: 10.1016/j.ajog.2018.05.013. PubMed DOI

Seebacher V., Schmid M., Polterauer S., Hefler-Frischmuth K., Leipold H., Concin N., Reinthaller A., Hefler L. The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: A retrospective multi-center study. BMC Cancer. 2009;9:460. doi: 10.1186/1471-2407-9-460. PubMed DOI PMC

Barak F., Kalichman L., Gdalevich M., Milgrom R., Laitman Y., Piura B., Lavie O., Gemer O. The influence of early diagnosis of endometrioid endometrial cancer on disease stage and survival. Arch. Gynecol. Obstet. 2013;288:1361–1364. doi: 10.1007/s00404-013-2898-5. PubMed DOI

Namazov A., Helpman L., Eitan R., Vaknin Z., Lavie O., Ben-Arie A., Amit A., Levy T., Volodarsky M., Atlas I., et al. The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: An Israel gynecologic oncology group study. Maturitas. 2021;148:18–23. doi: 10.1016/j.maturitas.2021.04.001. PubMed DOI